Recently, Halama et al. reported that CCL5 produced by T lymphocytes in CRC liver metastases has tumor-promoting effects on tumor cells and tumor-associated macrophages (TAMs), and that the CCR5 inhibitor, maraviroc, led to tumor reduction through repolarization of TAMs38. The gene discussed is CCR5; the disease is colorectal carcinoma.